TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
Haderski, Gary J, Kandar, Bojidar M, Brackett, Craig M, Toshkov, Ilia M, Johnson, Christopher P, Paszkiewicz, Geraldine M, Natarajan, Venkatesh, Gleiberman, Anatoli S, Gudkov, Andrei V, Burdelya, Lyudmila G
Published in PloS one (06.02.2020)
Published in PloS one (06.02.2020)
Get full text
Journal Article